Pub Date : 2026-06-01Epub Date: 2026-01-30DOI: 10.1016/j.nupar.2026.103031
Omer Qutaiba B. Allela , Abdulkareem Shareef , Hayder Naji Sameer , Ahmed Yaseen , Zainab H. Athab , Mohaned Adil
Objectives
Food and nutrition literacy (FNL), the ability to access, understand, evaluate, and apply nutrition information, is increasingly recognized as a critical determinant of dietary behavior and chronic disease outcomes. This scoping review aimed to synthesize global evidence on the prevalence, measurement approaches, and clinical and behavioral correlates of FNL among adults living with non-communicable diseases (NCDs), and to clarify its relevance for clinical care and public health practice.
Material and methods
Following the PRISMA-ScR guidelines, PubMed, Scopus, Web of Science, and Google Scholar were systematically searched for peer-reviewed studies up to October 30, 2025. Eligible studies assessed functional, interactive, or critical FNL in adults with NCDs. Data were extracted on study characteristics, FNL measurement, and associations with behavioral or clinical outcomes. Two researchers independently performed searches of electronic databases, study selection, and data extraction, with discrepancies resolved by consensus or a third reviewer.
Results
Thirteen studies, covering 5004 participants across diverse settings, were included. FNL levels were generally suboptimal, with pronounced deficits in label interpretation, portion control, meal planning, and critical appraisal. Higher FNL was consistently associated with healthier dietary behaviors, improved self-management, and better cardiometabolic indicators. Functional literacy supported adherence to evidence-based diets, while interactive and critical literacy enhanced patient-provider communication and resilience against misleading nutrition information.
Conclusion
FNL is a modifiable, clinically actionable determinant of chronic disease management. Integrating FNL assessment and education into care pathways can empower patients, strengthen long-term adherence, and support population-level NCD prevention.
食品和营养素养(FNL),即获取、理解、评估和应用营养信息的能力,越来越被认为是饮食行为和慢性疾病结局的关键决定因素。本综述旨在综合全球非传染性疾病(NCDs)成人中FNL患病率、测量方法以及临床和行为相关性的证据,并阐明其与临床护理和公共卫生实践的相关性。材料和方法按照PRISMA-ScR指南,系统检索PubMed、Scopus、Web of Science和b谷歌Scholar,检索截止到2025年10月30日的同行评议研究。符合条件的研究评估了非传染性疾病成人的功能性、互动性或关键性FNL。提取有关研究特征、FNL测量以及与行为或临床结果的关联的数据。两名研究人员独立进行电子数据库搜索、研究选择和数据提取,差异由共识或第三方审稿人解决。结果纳入13项研究,涵盖5004名不同环境的参与者。FNL水平通常是次优的,在标签解释、份量控制、膳食计划和批判性评价方面存在明显缺陷。较高的FNL始终与更健康的饮食行为、改善的自我管理和更好的心脏代谢指标相关。功能性读写能力支持对循证饮食的坚持,而互动性和批判性读写能力增强了患者与提供者之间的沟通和抵御误导性营养信息的能力。结论fnl是一种可改变的、临床可操作的慢性疾病治疗决定因素。将FNL评估和教育纳入护理途径可以增强患者的权能,加强长期依从性,并支持人群层面的非传染性疾病预防。
{"title":"Mapping food and nutrition literacy in non-communicable disease contexts: A scoping review","authors":"Omer Qutaiba B. Allela , Abdulkareem Shareef , Hayder Naji Sameer , Ahmed Yaseen , Zainab H. Athab , Mohaned Adil","doi":"10.1016/j.nupar.2026.103031","DOIUrl":"10.1016/j.nupar.2026.103031","url":null,"abstract":"<div><h3>Objectives</h3><div>Food and nutrition literacy (FNL), the ability to access, understand, evaluate, and apply nutrition information, is increasingly recognized as a critical determinant of dietary behavior and chronic disease outcomes. This scoping review aimed to synthesize global evidence on the prevalence, measurement approaches, and clinical and behavioral correlates of FNL among adults living with non-communicable diseases (NCDs), and to clarify its relevance for clinical care and public health practice.</div></div><div><h3>Material and methods</h3><div>Following the PRISMA-ScR guidelines, PubMed, Scopus, Web of Science, and Google Scholar were systematically searched for peer-reviewed studies up to October 30, 2025. Eligible studies assessed functional, interactive, or critical FNL in adults with NCDs. Data were extracted on study characteristics, FNL measurement, and associations with behavioral or clinical outcomes. Two researchers independently performed searches of electronic databases, study selection, and data extraction, with discrepancies resolved by consensus or a third reviewer.</div></div><div><h3>Results</h3><div>Thirteen studies, covering 5004 participants across diverse settings, were included. FNL levels were generally suboptimal, with pronounced deficits in label interpretation, portion control, meal planning, and critical appraisal. Higher FNL was consistently associated with healthier dietary behaviors, improved self-management, and better cardiometabolic indicators. Functional literacy supported adherence to evidence-based diets, while interactive and critical literacy enhanced patient-provider communication and resilience against misleading nutrition information.</div></div><div><h3>Conclusion</h3><div>FNL is a modifiable, clinically actionable determinant of chronic disease management. Integrating FNL assessment and education into care pathways can empower patients, strengthen long-term adherence, and support population-level NCD prevention.</div></div>","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"40 2","pages":"Article 103031"},"PeriodicalIF":0.4,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146080693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The COVID-19 pandemic has revealed substantial heterogeneity in biomarker profiles associated with disease severity. While inflammation-driven responses are implicated in progression to critical illness, the role of nutritional status and micronutrient levels in shaping outcomes remains incompletely understood. This study integrates 35 studies using a multi-visual meta-analytic approach to delineate the relationships between inflammatory biomarkers, nutritional/vitamin markers, and severe COVID-19 outcomes.
Methods
We conducted a systematic search of major databases (PubMed/MEDLINE, Embase, and Web of Science) for studies reporting quantitative associations between serum biomarkers and COVID-19 severity or mortality. Data were harmonized to standardized mean differences (SMDs) where possible. A multi-plot synthesis (forest, funnel, volcano, and bubble plots) was employed to capture effect sizes, precision, heterogeneity, publication bias, and variance. Inclusion criteria encompassed adult participants with confirmed SARS-CoV-2 infection who reported inflammatory markers (CRP, IL-6, ferritin), nutritional markers (e.g., albumin, pre-albumin), vitamins (e.g., A, C, D, E), and immune markers, where available. Exclusion criteria included pediatric populations and studies lacking extractable quantitative data.
Results
Across 35 studies, inflammatory biomarkers were consistently elevated in severe COVID-19, with CRP, IL-6, and ferritin showing directionally positive associations with adverse outcomes. Nutritional and micronutrient markers tended to be reduced in severe cases, with albumin and several vitamins (notably vitamin D, C, and E) frequently depleted, though substantial between-study heterogeneity existed. The integrated visualizations revealed concordant signals of inflammation amid variable nutritional statuses, while funnel plots suggested modest small-study effects that did not materially alter the overall conclusions. Sensitivity analyses confirmed robustness of the main inflammation-associated findings and highlighted context-dependent variability for nutritional markers. Collectively, the results underscore a central inflammatory axis in severe COVID-19, modulated by nutritional and micronutrient status, with implications for risk stratification and supportive care strategies.
Conclusions
Our multi-plot synthesis provides a cohesive narrative linking systemic inflammation with adverse outcomes in COVID-19 and delineates nuanced roles for nutritional and vitamin-related factors. These findings support concurrent emphasis on anti-inflammatory management and nutritional optimization in high-risk patients, while also guiding future research to disentangle context-specific moderators and to test targeted nutritional interventions.
背景:2019冠状病毒病大流行揭示了与疾病严重程度相关的生物标志物谱的巨大异质性。虽然炎症驱动的反应与危重疾病的进展有关,但营养状况和微量营养素水平在形成结果中的作用仍未完全了解。本研究整合了35项研究,使用多视觉荟萃分析方法来描述炎症生物标志物、营养/维生素标志物与COVID-19严重结局之间的关系。方法系统检索主要数据库(PubMed/MEDLINE、Embase和Web of Science),查找报告血清生物标志物与COVID-19严重程度或死亡率之间定量关联的研究。在可能的情况下,将数据统一为标准化平均差异(SMDs)。采用多图综合(森林、漏斗、火山和气泡图)来捕获效应大小、精度、异质性、发表偏倚和方差。纳入标准包括确诊为SARS-CoV-2感染的成年参与者,他们报告了炎症标志物(CRP、IL-6、铁蛋白)、营养标志物(如白蛋白、白蛋白前体)、维生素(如A、C、D、E)和免疫标志物(如有)。排除标准包括儿科人群和缺乏可提取定量数据的研究。结果在35项研究中,炎症生物标志物在严重的COVID-19中持续升高,CRP、IL-6和铁蛋白与不良结局呈方向性正相关。在严重的病例中,营养和微量营养素标志物倾向于减少,白蛋白和几种维生素(特别是维生素D、C和E)经常耗尽,尽管研究之间存在大量异质性。综合可视化显示了不同营养状态下炎症的一致信号,而漏斗图显示了适度的小型研究效应,但并未实质性地改变总体结论。敏感性分析证实了主要炎症相关发现的稳健性,并强调了营养标志物的环境依赖性变异性。总的来说,这些结果强调了重症COVID-19的中心炎症轴,受营养和微量营养素状况的调节,对风险分层和支持性护理策略具有重要意义。结论sour多图综合为COVID-19的全身性炎症与不良结局之间的联系提供了一个连贯的叙事,并描绘了营养和维生素相关因素的微妙作用。这些发现支持在高风险患者中同时强调抗炎管理和营养优化,同时也指导未来的研究解开特定情境的调节因子并测试有针对性的营养干预措施。
{"title":"Integrating inflammation and nutrition: A multi-visual meta-analysis of serum biomarkers and COVID-19 severity","authors":"Nayebali Ahmadi , Maryam Shahali , Mohammad Javad Hossein Tehrani , Danial Sarlak , Rajab Mardani","doi":"10.1016/j.nupar.2026.103034","DOIUrl":"10.1016/j.nupar.2026.103034","url":null,"abstract":"<div><h3>Background</h3><div>The COVID-19 pandemic has revealed substantial heterogeneity in biomarker profiles associated with disease severity. While inflammation-driven responses are implicated in progression to critical illness, the role of nutritional status and micronutrient levels in shaping outcomes remains incompletely understood. This study integrates 35 studies using a multi-visual meta-analytic approach to delineate the relationships between inflammatory biomarkers, nutritional/vitamin markers, and severe COVID-19 outcomes.</div></div><div><h3>Methods</h3><div>We conducted a systematic search of major databases (PubMed/MEDLINE, Embase, and Web of Science) for studies reporting quantitative associations between serum biomarkers and COVID-19 severity or mortality. Data were harmonized to standardized mean differences (SMDs) where possible. A multi-plot synthesis (forest, funnel, volcano, and bubble plots) was employed to capture effect sizes, precision, heterogeneity, publication bias, and variance. Inclusion criteria encompassed adult participants with confirmed SARS-CoV-2 infection who reported inflammatory markers (CRP, IL-6, ferritin), nutritional markers (e.g., albumin, pre-albumin), vitamins (e.g., A, C, D, E), and immune markers, where available. Exclusion criteria included pediatric populations and studies lacking extractable quantitative data.</div></div><div><h3>Results</h3><div>Across 35 studies, inflammatory biomarkers were consistently elevated in severe COVID-19, with CRP, IL-6, and ferritin showing directionally positive associations with adverse outcomes. Nutritional and micronutrient markers tended to be reduced in severe cases, with albumin and several vitamins (notably vitamin D, C, and E) frequently depleted, though substantial between-study heterogeneity existed. The integrated visualizations revealed concordant signals of inflammation amid variable nutritional statuses, while funnel plots suggested modest small-study effects that did not materially alter the overall conclusions. Sensitivity analyses confirmed robustness of the main inflammation-associated findings and highlighted context-dependent variability for nutritional markers. Collectively, the results underscore a central inflammatory axis in severe COVID-19, modulated by nutritional and micronutrient status, with implications for risk stratification and supportive care strategies.</div></div><div><h3>Conclusions</h3><div>Our multi-plot synthesis provides a cohesive narrative linking systemic inflammation with adverse outcomes in COVID-19 and delineates nuanced roles for nutritional and vitamin-related factors. These findings support concurrent emphasis on anti-inflammatory management and nutritional optimization in high-risk patients, while also guiding future research to disentangle context-specific moderators and to test targeted nutritional interventions.</div></div>","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"40 2","pages":"Article 103034"},"PeriodicalIF":0.4,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146190206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2026-02-02DOI: 10.1016/j.nupar.2026.103032
Yang Heng , Yang Qiuming
The global pandemic of metabolic diseases, such as obesity and type 2 diabetes, underscores an urgent need for innovative therapeutic strategies. Emerging evidence has established the intestine as a central player in nutrient sensing and systemic metabolic regulation. This review systematically delineates the critical role of the sodium-glucose cotransporter 1 (SGLT-1) in metabolic control and elaborates on the molecular mechanisms through which glucagon-like peptide-1 (GLP-1) modulates metabolic homeostasis via the brain-gut-taste axis. By reviewing and integrating recent evidence, we propose a novel paradigm wherein GLP-1, through the modulation of intestinal SGLT-1 signaling, influences taste perception and food preferences, thereby orchestrating systemic metabolic outcomes. This mechanism provides a compelling rationale for developing therapies that would target the gut-brain axis, representing a potential breakthrough in managing metabolic disorders. Finally, we outline current limitations and future challenges in translating these insights into clinical practice, to propose a framework for guiding research in this promising field.
{"title":"Targeting the brain-gut-taste axis: The role of GLP-1-mediated SGLT-1 signaling in metabolic diseases","authors":"Yang Heng , Yang Qiuming","doi":"10.1016/j.nupar.2026.103032","DOIUrl":"10.1016/j.nupar.2026.103032","url":null,"abstract":"<div><div>The global pandemic of metabolic diseases, such as obesity and type 2 diabetes, underscores an urgent need for innovative therapeutic strategies. Emerging evidence has established the intestine as a central player in nutrient sensing and systemic metabolic regulation. This review systematically delineates the critical role of the sodium-glucose cotransporter 1 (SGLT-1) in metabolic control and elaborates on the molecular mechanisms through which glucagon-like peptide-1 (GLP-1) modulates metabolic homeostasis via the brain-gut-taste axis. By reviewing and integrating recent evidence, we propose a novel paradigm wherein GLP-1, through the modulation of intestinal SGLT-1 signaling, influences taste perception and food preferences, thereby orchestrating systemic metabolic outcomes. This mechanism provides a compelling rationale for developing therapies that would target the gut-brain axis, representing a potential breakthrough in managing metabolic disorders. Finally, we outline current limitations and future challenges in translating these insights into clinical practice, to propose a framework for guiding research in this promising field.</div></div>","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"40 2","pages":"Article 103032"},"PeriodicalIF":0.4,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146190207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2026-01-23DOI: 10.1016/j.nupar.2025.103029
Qiang Lu , Lei Zhang , Yan Wang , Huaiyu Hao
Objective
This study with a systematic review and meta-analysis design aimed to specially investigate the relationship between dietary fiber intake and chronic obstructive pulmonary disease.
Materials and methods
A search was performed in the databases of Web of Science, PubMed, and Scopus. The articles retrieved from these databases were carefully reviewed and screened by the research team. Ultimately, articles that met the established inclusion and exclusion criteria were selected for data extraction. The quality of these studies was evaluated using the Joanna Briggs Institute (JBI) critical appraisal instruments. To integrate the findings, a meta-analysis was performed to aggregate the reported odds ratios and hazard ratios from the chosen studies.
Results
Fifteen studies were entered into the review. Thirteen of 15 reviewed papers (86.7 percent) revealed that there is an association between dietary fiber intake and risk of COPD. The values of the odds ratio and hazard ratio related to the impact of fiber consumption on the decreased risk of COPD were between 0.46 to 0.98 and 0.54 to 0.70. The results of meta-analysis showed that fiber intake can decrease the risk of COPD [odd ratio: 0.866 (95% CI: 0.773–0.971); P = 0.014; I2 = 79.30 and hazard ratio: 0.636 (95% CI: 0.538–0.751); P < 0.001; I2 = 41.29].
Conclusion
The results showed that fiber intake can significantly reduce the risk of COPD. Hence, it is suggested that dietary plans on fiber intake are implemented, especially in poor countries.
{"title":"The association between dietary fiber consumption and chronic obstructive pulmonary disease: A systematic review and meta-analysis","authors":"Qiang Lu , Lei Zhang , Yan Wang , Huaiyu Hao","doi":"10.1016/j.nupar.2025.103029","DOIUrl":"10.1016/j.nupar.2025.103029","url":null,"abstract":"<div><h3>Objective</h3><div>This study with a systematic review and meta-analysis design aimed to specially investigate the relationship between dietary fiber intake and chronic obstructive pulmonary disease.</div></div><div><h3>Materials and methods</h3><div>A search was performed in the databases of Web of Science, PubMed, and Scopus. The articles retrieved from these databases were carefully reviewed and screened by the research team. Ultimately, articles that met the established inclusion and exclusion criteria were selected for data extraction. The quality of these studies was evaluated using the Joanna Briggs Institute (JBI) critical appraisal instruments. To integrate the findings, a meta-analysis was performed to aggregate the reported odds ratios and hazard ratios from the chosen studies.</div></div><div><h3>Results</h3><div>Fifteen studies were entered into the review. Thirteen of 15 reviewed papers (86.7 percent) revealed that there is an association between dietary fiber intake and risk of COPD. The values of the odds ratio and hazard ratio related to the impact of fiber consumption on the decreased risk of COPD were between 0.46 to 0.98 and 0.54 to 0.70. The results of meta-analysis showed that fiber intake can decrease the risk of COPD [odd ratio: 0.866 (95% CI: 0.773–0.971); <em>P</em> <!-->=<!--> <!-->0.014; I<sup>2</sup> <!-->=<!--> <!-->79.30 and hazard ratio: 0.636 (95% CI: 0.538–0.751); <em>P</em> <!--><<!--> <!-->0.001; I<sup>2</sup> <!-->=<!--> <!-->41.29].</div></div><div><h3>Conclusion</h3><div>The results showed that fiber intake can significantly reduce the risk of COPD. Hence, it is suggested that dietary plans on fiber intake are implemented, especially in poor countries.</div></div>","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"40 2","pages":"Article 103029"},"PeriodicalIF":0.4,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146039467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2026-01-21DOI: 10.1016/j.nupar.2025.103028
Jade Deglaire, Thomas Mouillot
Malnutrition – particularly in anorexia nervosa – can have significant hepatic repercussions. As the central organ of metabolism, the liver is particularly vulnerable to nutritional disturbances. Two principal forms of hepatitis related to malnutrition have been described in the literature: starvation hepatitis and refeeding-induced hepatitis. The former mainly results from excessive hepatocellular autophagy and hypoxia due to dehydration and hypovolemia, and is usually associated with clinical symptoms. In contrast, the latter is frequently linked to inappropriate refeeding syndrome, is clinically asymptomatic, and occurs during overly rapid or calorie-dense refeeding, leading to hepatic steatosis. This article is based on an international literature review highlighting diagnostic criteria, pathophysiological mechanisms (autophagy, hypoxia, steatosis), specific risks, and therapeutic management of liver diseases associated with malnutrition in the context of anorexia nervosa.
{"title":"Atteintes hépatiques en lien avec la dénutrition dans l’anorexie mentale – Revue de la littérature","authors":"Jade Deglaire, Thomas Mouillot","doi":"10.1016/j.nupar.2025.103028","DOIUrl":"10.1016/j.nupar.2025.103028","url":null,"abstract":"<div><div>Malnutrition – particularly in anorexia nervosa – can have significant hepatic repercussions. As the central organ of metabolism, the liver is particularly vulnerable to nutritional disturbances. Two principal forms of hepatitis related to malnutrition have been described in the literature: starvation hepatitis and refeeding-induced hepatitis. The former mainly results from excessive hepatocellular autophagy and hypoxia due to dehydration and hypovolemia, and is usually associated with clinical symptoms. In contrast, the latter is frequently linked to inappropriate refeeding syndrome, is clinically asymptomatic, and occurs during overly rapid or calorie-dense refeeding, leading to hepatic steatosis. This article is based on an international literature review highlighting diagnostic criteria, pathophysiological mechanisms (autophagy, hypoxia, steatosis), specific risks, and therapeutic management of liver diseases associated with malnutrition in the context of anorexia nervosa.</div></div>","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"40 2","pages":"Article 103028"},"PeriodicalIF":0.4,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146006588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
To evaluate the impact of increasing dietitian presence in an orthopedic surgery department on malnutrition screening and the associated healthcare revenue.
Methods
A retrospective observational study was conducted in the orthopedic surgery department of a hospital over two consecutive periods (January and February 2023). The allocated dietitian time was increased from 10 to 50%. Data collected included the number of patients hospitalized for more than 48 hours, dietitian consultations, malnutrition diagnoses, upgraded Diagnosis-Related Group (DRG) classifications, and the corresponding financial valuation.
Results
The increase in dietitian time led to a significant rise in dietetic consultations (15.2 vs. 83.8%; P < 0.001), malnutrition diagnoses (7 vs. 26; P = 0.0039), and upgraded hospital stays (5 vs. 15). Monthly financial valuation quadrupled from €9,517 to €41,801. The malnutrition coding rate in the department increased from 6.7 to 18.3%, while it remained stable at the institutional level.
Conclusion
Enhancing dietitian presence significantly improved malnutrition screening and coding, with substantial financial impact. This reorganization highlights the value of increasing human resources dedicated to hospital nutrition. It contributes to improved quality of care and resource optimization, aligning with the objectives of the French National Nutrition and Health Program (PNNS).
目的评价骨科增加营养师对营养不良筛查及相关医疗收入的影响。方法于2023年1月和2月连续两期在某医院骨科进行回顾性观察研究。分配给营养师的时间从10%增加到50%。收集的数据包括住院超过48小时的患者人数、营养师咨询、营养不良诊断、升级的诊断相关组(DRG)分类以及相应的财务评估。结果营养师时间的增加导致饮食咨询(15.2 vs. 83.8%; P < 0.001)、营养不良诊断(7 vs. 26; P = 0.0039)和住院时间(5 vs. 15)显著增加。每月财务估值翻了两番,从9517欧元增至41801欧元。该科的营养不良编码率从6.7上升到18.3%,而在机构层面保持稳定。结论增加营养学家的存在可显著改善营养不良筛查和编码,并具有显著的经济效益。这一重组凸显了增加专门用于医院营养的人力资源的价值。它有助于提高护理质量和优化资源,符合法国国家营养和健康方案的目标。
{"title":"Impact de l’augmentation du temps diététique sur le dépistage et la valorisation médicoéconomique de la dénutrition en chirurgie orthopédique","authors":"Vérane Peyratout Gueho , Simon Atmeare , Clarysse Addario , Marine Tourscher , Emilie Racano","doi":"10.1016/j.nupar.2026.103030","DOIUrl":"10.1016/j.nupar.2026.103030","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the impact of increasing dietitian presence in an orthopedic surgery department on malnutrition screening and the associated healthcare revenue.</div></div><div><h3>Methods</h3><div>A retrospective observational study was conducted in the orthopedic surgery department of a hospital over two consecutive periods (January and February 2023). The allocated dietitian time was increased from 10 to 50%. Data collected included the number of patients hospitalized for more than 48<!--> <!-->hours, dietitian consultations, malnutrition diagnoses, upgraded Diagnosis-Related Group (DRG) classifications, and the corresponding financial valuation.</div></div><div><h3>Results</h3><div>The increase in dietitian time led to a significant rise in dietetic consultations (15.2 vs. 83.8%; <em>P</em> <!--><<!--> <!-->0.001), malnutrition diagnoses (7 vs. 26; <em>P</em> <!-->=<!--> <!-->0.0039), and upgraded hospital stays (5 vs. 15). Monthly financial valuation quadrupled from €9,517 to €41,801. The malnutrition coding rate in the department increased from 6.7 to 18.3%, while it remained stable at the institutional level.</div></div><div><h3>Conclusion</h3><div>Enhancing dietitian presence significantly improved malnutrition screening and coding, with substantial financial impact. This reorganization highlights the value of increasing human resources dedicated to hospital nutrition. It contributes to improved quality of care and resource optimization, aligning with the objectives of the French National Nutrition and Health Program (PNNS).</div></div>","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"40 2","pages":"Article 103030"},"PeriodicalIF":0.4,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146080694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-19DOI: 10.1016/j.nupar.2026.103035
Didier Quilliot
{"title":"L’éditorial du président de la SNFCM","authors":"Didier Quilliot","doi":"10.1016/j.nupar.2026.103035","DOIUrl":"10.1016/j.nupar.2026.103035","url":null,"abstract":"","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"40 1","pages":"Article 103035"},"PeriodicalIF":0.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147396493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-12-13DOI: 10.1016/j.nupar.2025.11.004
Xiaoyang Zhang , Xiaomin Lin , Yahui Sun , Qingfeng Zeng , Yurong Liang , Wenfei Zha , Na Mi , Weijie Gu
Background
Coffee, one of the most globally consumed beverages with annual trade volumes exceeding $10 billion USD, has been epidemiologically associated with gastrointestinal effects due to its bioactive constituents, particularly caffeine. While previous studies have suggested potential impacts of coffee consumption on digestive physiology, the precise mechanisms and dose-response relationships remain poorly characterized. This cross-sectional investigation utilizes nationally representative data from the National Health and Nutrition Examination Survey (NHANES) to systematically examine the association between coffee intake patterns and diarrheal incidence in the U.S. adult population.
Methods
This study conducted a cross-sectional analysis of self-reported diarrhea and coffee intake from the 2005–2020 National Health and Nutrition Examination Survey (NHANES). Weighted multivariable logistic regression models and restricted cubic splines (RCS) were employed to assess the association between coffee consumption and diarrhea, with results presented as odds ratios (ORs) and 95% confidence intervals (CIs).
Results
In this observational study, a total of 9544 eligible participants were included. After adjusting for potential confounding variables, higher coffee consumption was associated with an increased risk of diarrhea compared to lower coffee consumption, regardless of whether intake was measured in grams (P overall = 0.01) or cups (P overall = 0.04). Furthermore, a restricted cubic spline (RCS) analysis revealed a statistically significant linear positive correlation between coffee intake and diarrhea risk (P for nonlinearity < 0.05).
Conclusion
This population-based study demonstrates a statistically significant association between coffee intake and the incidence of diarrhea, regardless of whether consumption is measured in grams or cups. Therefore, individuals prone to gastrointestinal discomfort may benefit from moderating their coffee intake to reduce the risk of diarrhea.
{"title":"The relationship between coffee consumption and diarrhea: A cross-sectional study based on NHANES data","authors":"Xiaoyang Zhang , Xiaomin Lin , Yahui Sun , Qingfeng Zeng , Yurong Liang , Wenfei Zha , Na Mi , Weijie Gu","doi":"10.1016/j.nupar.2025.11.004","DOIUrl":"10.1016/j.nupar.2025.11.004","url":null,"abstract":"<div><h3>Background</h3><div>Coffee, one of the most globally consumed beverages with annual trade volumes exceeding $10<!--> <!-->billion USD, has been epidemiologically associated with gastrointestinal effects due to its bioactive constituents, particularly caffeine. While previous studies have suggested potential impacts of coffee consumption on digestive physiology, the precise mechanisms and dose-response relationships remain poorly characterized. This cross-sectional investigation utilizes nationally representative data from the National Health and Nutrition Examination Survey (NHANES) to systematically examine the association between coffee intake patterns and diarrheal incidence in the U.S. adult population.</div></div><div><h3>Methods</h3><div>This study conducted a cross-sectional analysis of self-reported diarrhea and coffee intake from the 2005–2020 National Health and Nutrition Examination Survey (NHANES). Weighted multivariable logistic regression models and restricted cubic splines (RCS) were employed to assess the association between coffee consumption and diarrhea, with results presented as odds ratios (ORs) and 95% confidence intervals (CIs).</div></div><div><h3>Results</h3><div>In this observational study, a total of 9544 eligible participants were included. After adjusting for potential confounding variables, higher coffee consumption was associated with an increased risk of diarrhea compared to lower coffee consumption, regardless of whether intake was measured in grams (<em>P</em> overall<!--> <!-->=<!--> <!-->0.01) or cups (<em>P</em> overall<!--> <!-->=<!--> <!-->0.04). Furthermore, a restricted cubic spline (RCS) analysis revealed a statistically significant linear positive correlation between coffee intake and diarrhea risk (<em>P</em> for nonlinearity<!--> <!--><<!--> <!-->0.05).</div></div><div><h3>Conclusion</h3><div>This population-based study demonstrates a statistically significant association between coffee intake and the incidence of diarrhea, regardless of whether consumption is measured in grams or cups. Therefore, individuals prone to gastrointestinal discomfort may benefit from moderating their coffee intake to reduce the risk of diarrhea.</div></div>","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"40 1","pages":"Article 103020"},"PeriodicalIF":0.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145750055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This study aimed to synthesize available evidence on the impact of vitamin D supplementation on COVID-19-related mortality through a systematic review and meta-analysis.
Methods
We systematically searched major databases for randomized controlled trials (RCTs), quasi-RCTs, and cluster-randomized trials published between October 1, 2019, and December 14, 2024, evaluating vitamin D supplementation in adult patients with laboratory-confirmed COVID-19. Studies were included if they reported mortality outcomes and compared vitamin D with placebo, standard care, or no intervention. Risk of bias was assessed using the Cochrane tool. Pooled odds ratios (ORs) were calculated using a random-effects model. Subgroup analyses were performed by age and sex composition. Publication bias was assessed via funnel plot symmetry and Egger's test.
Results
A total of 24 studies encompassing diverse populations across hospital, ICU, and community settings were included. Sample sizes ranged from 32 to 6200 participants, and intervention durations from 5 to 180 days. A pooled analysis revealed that vitamin D supplementation was associated with a significant 33% reduction in COVID-19 mortality (OR = 0.67; 95% CI: 0.46–0.98; P = 0.04), with moderate heterogeneity (I2 = 48.2%). Subgroup analysis revealed a greater benefit among patients aged 65 years or older (minimal heterogeneity; I2 = 4.3%) and among studies with more than 50% female participants (OR = 0.47; P = 0.01). No significant publication bias was detected.
Conclusions
Vitamin D may confer a protective effect against COVID-19 mortality, particularly among older adults and women. It represents a promising adjunctive strategy in COVID-19 management.
背景与目的本研究旨在通过系统回顾和荟萃分析,综合现有证据,证明补充维生素D对covid -19相关死亡率的影响。方法系统检索2019年10月1日至2024年12月14日发表的随机对照试验(rct)、准rct和集群随机试验的主要数据库,评估实验室确诊的成人COVID-19患者补充维生素D的效果。如果研究报告了死亡率结果,并将维生素D与安慰剂、标准治疗或无干预进行比较,则纳入研究。使用Cochrane工具评估偏倚风险。采用随机效应模型计算合并优势比(ORs)。按年龄和性别组成进行亚组分析。通过漏斗图对称和Egger检验评估发表偏倚。结果共纳入了24项研究,涵盖了医院、ICU和社区环境中的不同人群。样本量为32至6200名参与者,干预时间为5至180天。一项汇总分析显示,补充维生素D与COVID-19死亡率显著降低33%相关(OR = 0.67; 95% CI: 0.46-0.98; P = 0.04),具有中等异质性(I2 = 48.2%)。亚组分析显示,65岁及以上的患者(最小异质性;I2 = 4.3%)和女性参与者超过50%的研究(or = 0.47; P = 0.01)获益更大。未发现显著的发表偏倚。结论:维生素D可能具有预防COVID-19死亡率的保护作用,特别是在老年人和妇女中。它代表了一种很有前途的COVID-19管理辅助策略。
{"title":"Impact of vitamin D supplementation on COVID-19 mortality: A systematic review and meta-analysis","authors":"Azam Doustmohammadian , Maryam Amini , Bahareh Nikooyeh , Maryam Hajigholam-Saryazdi , Sepideh Alibeyk , Melika Hajjar","doi":"10.1016/j.nupar.2025.12.001","DOIUrl":"10.1016/j.nupar.2025.12.001","url":null,"abstract":"<div><h3>Background and aims</h3><div>This study aimed to synthesize available evidence on the impact of vitamin D supplementation on COVID-19-related mortality through a systematic review and meta-analysis.</div></div><div><h3>Methods</h3><div>We systematically searched major databases for randomized controlled trials (RCTs), quasi-RCTs, and cluster-randomized trials published between October 1, 2019, and December 14, 2024, evaluating vitamin D supplementation in adult patients with laboratory-confirmed COVID-19. Studies were included if they reported mortality outcomes and compared vitamin D with placebo, standard care, or no intervention. Risk of bias was assessed using the Cochrane tool. Pooled odds ratios (ORs) were calculated using a random-effects model. Subgroup analyses were performed by age and sex composition. Publication bias was assessed via funnel plot symmetry and Egger's test.</div></div><div><h3>Results</h3><div>A total of 24 studies encompassing diverse populations across hospital, ICU, and community settings were included. Sample sizes ranged from 32 to 6200 participants, and intervention durations from 5 to 180<!--> <!-->days. A pooled analysis revealed that vitamin D supplementation was associated with a significant 33% reduction in COVID-19 mortality (OR<!--> <!-->=<!--> <!-->0.67; 95% CI: 0.46–0.98; <em>P</em> <!-->=<!--> <!-->0.04), with moderate heterogeneity (I<sup>2</sup> <!-->=<!--> <!-->48.2%). Subgroup analysis revealed a greater benefit among patients aged 65<!--> <!-->years or older (minimal heterogeneity; I<sup>2</sup> <!-->=<!--> <!-->4.3%) and among studies with more than 50% female participants (OR<!--> <!-->=<!--> <!-->0.47; <em>P</em> <!-->=<!--> <!-->0.01). No significant publication bias was detected.</div></div><div><h3>Conclusions</h3><div>Vitamin D may confer a protective effect against COVID-19 mortality, particularly among older adults and women. It represents a promising adjunctive strategy in COVID-19 management.</div></div>","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"40 1","pages":"Article 103022"},"PeriodicalIF":0.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145841512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-01-12DOI: 10.1016/j.nupar.2025.12.002
Mohamed Guda , Aseel Almagrabi , Muhammed Zahri , Nada A. Alshaikh , Elsayed Ghoneem
Chronic inflammatory esophageal illness, also known as eosinophilic esophagitis (EoE), is mostly caused by immunological responses mediated by T-helper 2 (Th2) cells. Dysphagia, chest pain, and regurgitation are some of the symptoms that can be seen in both adults and children. Specific histological criteria usually lead to a diagnosis of the condition, which is marked by eosinophilic infiltration of the esophagus. It is more common in men, and the incidence and prevalence of EoE are on the rise, especially in high-income nations. The etiology of EoE is influenced by both hereditary and environmental factors. In order to manage EoE effectively, it is necessary to deal with the inflammatory and fibrostenotic components of the condition simultaneously. Efficacious dietary elimination programs, such as the 6-food elimination diet (6FED), are currently being used as therapies, along with proton pump inhibitors (PPIs) and topical corticosteroids. Dupilumab and other monoclonal antibodies that target the interleukin-4 receptor alpha are examples of biologic therapeutics that are showing promise as treatments, especially for patients who have not responded to conventional methods. Nevertheless, studies are still being conducted to determine the medicines’ long-term safety and effectiveness in various patient populations.
{"title":"Eosinophilic esophagitis; An updated review","authors":"Mohamed Guda , Aseel Almagrabi , Muhammed Zahri , Nada A. Alshaikh , Elsayed Ghoneem","doi":"10.1016/j.nupar.2025.12.002","DOIUrl":"10.1016/j.nupar.2025.12.002","url":null,"abstract":"<div><div>Chronic inflammatory esophageal illness, also known as eosinophilic esophagitis (EoE), is mostly caused by immunological responses mediated by T-helper 2 (Th2) cells. Dysphagia, chest pain, and regurgitation are some of the symptoms that can be seen in both adults and children. Specific histological criteria usually lead to a diagnosis of the condition, which is marked by eosinophilic infiltration of the esophagus. It is more common in men, and the incidence and prevalence of EoE are on the rise, especially in high-income nations. The etiology of EoE is influenced by both hereditary and environmental factors. In order to manage EoE effectively, it is necessary to deal with the inflammatory and fibrostenotic components of the condition simultaneously. Efficacious dietary elimination programs, such as the 6-food elimination diet (6FED), are currently being used as therapies, along with proton pump inhibitors (PPIs) and topical corticosteroids. Dupilumab and other monoclonal antibodies that target the interleukin-4 receptor alpha are examples of biologic therapeutics that are showing promise as treatments, especially for patients who have not responded to conventional methods. Nevertheless, studies are still being conducted to determine the medicines’ long-term safety and effectiveness in various patient populations.</div></div>","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"40 1","pages":"Article 103023"},"PeriodicalIF":0.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145977388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}